Astrocytes, which support diverse neuronal functions, are generated from multipotent neural stem/precursor cells (NS/PCs) during brain development. Although many astrocyte-inducing factors have been identified and studied in vitro, the regions and/or cells that produce these factors in the developing brain remain elusive. Here, we show that meninges-produced factors induce astrocytic differentiation of NS/PCs. Consistent with the timing when astrocytic differentiation of NS/PCs increases, expression of astrocyte-inducing factors is upregulated. Meningeal secretion-mimicking combinatorial treatment of NS/PCs with bone morphogenetic protein 4, retinoic acid and leukemia inhibitory factor synergistically activate the promoter of a typical astrocytic marker, glial fibrillary acidic protein. Taken together, our data suggest that meninges play an important role in astrocytic differentiation of NS/PCs in the developing brain.
Neural stem/precursor cells (NS/PCs) are defined as cells that can self-renew and can give rise to neurons and glial cells (astrocytes and oligodendrocytes) [1] [2] [3] . However, NS/PCs do not generally display this multipotency from the beginning of development. They first undergo symmetric division to expand their own pools and then switch to asymmetric division to produce neurons at mid-gestation. After the neurogenic phase, NS/PCs start to produce astrocytes at late embryonic stages [1, 2, [4] [5] [6] . Astrocytes are the most abundant cell type in the mammalian central nervous system, carrying out a wide variety of physiological functions including blood-brain barrier formation and maintenance, synaptogenesis, neurotransmission, and metabolic regulation [7] [8] [9] [10] . Since dysregulation of astrocyte development contributes to developmental and psychiatric disorders [3, 9, [11] [12] [13] [14] , elucidating the detailed mechanisms underlying astrogenesis in the developing brain would pave the way for the development of therapies to treat these disorders. It is well known that the generation of astrocytes from NS/PCs in culture can be induced by treatment with the interleukin-6 (IL-6) family of cytokines such as leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) and with bone morphogenetic proteins (BMPs) [8, [15] [16] [17] . IL-6 family cytokines promote Abbreviations AQP4, aquaporin 4; BMP, bone morphogenetic protein; CM, conditioned medium; CNTF, ciliary neurotrophic factor; CT-1, cardiotrophin-1; FoxC1, Forkhead box C; Gfap, glial fibrillary acidic protein; GF1L, Gfap promoter; Hes5, hairy and enhancer of split 5; IL-6, interleukin-6; LIF, leukemia inhibitory factor; NS/PCs, neural stem/precursor cells; RA, retinoic acid; Raldh2, retinaldehyde dehydrogenase 2; RAR, RA receptor; Rdh10, retinol dehydrogenase 10; RUX, ruxolitinib; STAT, signal transducer and activator of transcription; TGFb, transforming growth factor b; TUBB3, class III b tubulin; VZ/SVZ, ventricular/subventricular zone.
astrocyte differentiation via the activation of the gp130-janus kinase-signal transducer and activator of transcription (STAT) pathway [10, 16, 18, 19] . BMPs are members of the transforming growth factor b (TGFb) superfamily [17, 19, 20] . BMP signaling is transduced through heterotetrameric serine/threonine kinase receptors that phosphorylate pathway-restricted Smad1, 5 and 8. Phosphorylated Smad1/5/8 forms a complex with Smad4, and then, this complex translocates into the nucleus to initiate the transcription of its target genes [19, 20] . BMP-activated Smad1 forms a complex with LIF-activated STAT3 bridged by a transcriptional coactivator, p300 or CREB-binding protein (CBP), leading to synergistic induction of astrocytic differentiation of NS/PCs [15, 19] . Furthermore, we have previously shown that retinoic acid (RA) and LIF coordinately activate the transcription of an astrocyte-specific gene, glial fibrillary acidic protein (Gfap), in vitro [8, 21] . RA induces target gene expression through RA receptor (RAR), which functions primarily by forming heterodimers with retinoid X receptor and binds to RA response element in the promoter region of target genes. When RA binds to RAR, replacement of histone deacetylase with histone acetyl transferase occurs at target gene promoters, inducing histone acetylation around these sites, which relaxes the condensed chromatin structure [22] . In this context, it has been reported that such chromatin relaxation increases STAT binding to the Gfap promoter, explaining the cooperative LIF-RA induction of the gene [21] .
In spite of extensive studies regarding the mechanisms by which each factor activates astrocytic genes, the sources of the factors, i.e., regions and/or cells, which contribute to astrogenesis in the developing brain have not yet been fully elucidated. Where do astrocyte-inducing factors come from? It has been reported that embryonic cortical neurons express and secrete a member of the IL-6 family cytokines, cardiotrophin-1 (CT-1) [23] ; however, that report mainly focused on IL-6 family cytokines, and the contribution of other astrocyte-inducing factors was not investigated. In addition, comparison of embryonic neurons with other tissues and/or cells was not conducted, leaving the possibility that cells other than embryonic neurons could be a source of astrocyte-inducing factors in the developing brain. Recently, it was reported that meninges, which cover and protect the brain, act as a stem cell niche and regulate NS/PC proliferation and development [24, 25] . NS/PCs in the ventricular/subventricular zone (VZ/SVZ) extend their radial processes vertically and their basal end-feet attach to meninges, where they directly receive survival and differentiation signals such as BMPs and RA. Although the main focus of those studies was on neuronal differentiation, since BMPs and RA are also known to induce astrocytic differentiation of NS/PCs in vitro, we hypothesized that meninges can be a source of astrocyte-inducing factors in the developing brain.
In this study, we reveal that late-gestational meninges induce astrocytic differentiation of NS/PCs. Meninges express several genes of astrocyte-inducing factors, and their expression levels gradually increase, corresponding to the timing of the switch of NS/PC differentiation properties from neurogenic to astrogenic. We further demonstrate that the combination of meninges-expressing factors synergistically activates the Gfap promoter. These results suggest that meninges are one of the important sources of astrocyte-inducing factors in the developing brain.
Materials and methods

Cell culture
We obtained embryonic NS/PCs from time-pregnant ICR mice as previously described [15, 26] . In brief, telencephalons from E14 fetal mice were triturated in HBSS (Sigma-Aldrich, St. Louis, MO, USA) by frequent pipetting. After centrifugation, the cell pellet was resuspended in N2-supplemented DMEM/F-12 (Invitrogen, Carlsbad, CA, USA), containing 10 ngÁmL À1 recombinant human basic fibroblast growth factor (PeproTech, Rocky Hill, NJ, USA) and plated on dishes precoated with poly-L-ornithine (Sigma-Aldrich)/fibronectin (Sigma-Aldrich). Cells were expanded for 4 days and passaged for each experiment. Meningeal cells were isolated from E17 leptomeninges of telencephalons. After incubation with 0.5 gÁL À1 -Trypsin/ 0.53 mmolÁL À1 -EDTA Solution (Nacalai Tesque, Kyoto, Japan) at 37°C for 5 min, meninges were dissociated mechanically and cultured on 0.1% gelatin precoated dishes. After culturing in DMEM (Nacalai Tesque) containing 10% FBS and gentamycin for 3 h, the medium was changed and cells were expanded for 3 days. Neurons were isolated from E17 fetal cortex and triturated in HBSS, and dissociated cells were cultured on poly-L-lysine precoated dishes [27] . After culturing in MEM a (Gibco, Grand Island, NY, USA) containing 5% FBS and 0.6% glucose for 3 h, the medium was changed to Neurobasal containing 1/50 B27 supplement (Invitrogen), 1/100 GlutaMAX (Invitrogen). 1/2000 Cytosine b-D-arabinoside (AraC; SigmaAldrich) was added on day 1 to eliminate proliferating cells for the purification of neurons. 1/200 Antibiotic-Antimycotic (penicillin/streptomycin/amphotericin B) was added to all culture media. All cells were cultured at 37°C with 5% CO 2 in a humidified incubator.
Recombinant retrovirus construction and infection
To trace the fate of co-cultured NS/PCs, NS/PCs were infected with recombinant retroviruses engineered to express GFP. We used the retroviral vector pMY-IRES-GFP [28] , which contains an internal ribosome entry site followed by the GFP gene. Retrovirus was produced as previously described.
In brief, the Plat-E packaging cell [28, 29] line was transiently transfected with this construct using polyethylenimine MAX (Polysciences, Warrington, PA, USA). On the following day, the medium was replaced with N2-supplemented DMEM/F12 and the cells were cultured for 48 h before virus was collected.
Co-culture assay and immunostaining
After expansion for 3 or 4 days in the indicated medium in a humidified 37°C 5% CO 2 incubator, NS/PCs and meningeal cells were harvested and counted in order to adjust the cell number, and replated at a density of 2.5 9 10 5 cells per 3.5 cm dish and further cultured with GFP-labeled NS/PCs. For neurons, because they are fragile and not proliferative, we plated neuroncontaining cells from telencephalons at a density of 2.5 9 10 5 cells per 3.5 cm dish and cultured them for 3 days, and then these cells were directly used for the co-culture with GFPlabeled NS/PCs in N2-supplemented DMEM/F-12 (Invitrogen) for 4 days (Fig. 1A) . After a 4-day incubation in the same conditions as above, cells cultured on 3. 
Collection of conditioned medium
We collected CM from freshly isolated meningeal cells. Meningeal cells were isolated as described above from 10 fetal telencephalons. At 3 h after isolation, cells cultured on 60-mm dish were washed with PBS twice and the medium was changed from DMEM containing 10% FBS to N2-supplemented DMEM/F12. After the cells were cultured for 3 days, the supernatant was collected and filtered using a syringe filter (CA 0.45, 17598-K; Sartorius, Gottingen, Germany). To ascertain the ability of CM to induce astrocytic differentiation, NS/PCs were cultured for 4 days in N2-supplemented DMEM/F12 containing CM.
Quantitative real-time PCR
Total RNA was isolated using Sepasol-RNA I Super G (Nacalai Tesque) according to the manufacturer's instructions. A total of 500 ng RNA was used for first-strand cDNA synthesis with a SuperScript VILO cDNA Synthesis Kit (Invitrogen). PCR reactions were performed using a KAPA SYBR Fast qPCR Kit (KAPA Biosystems, Cape Town, South Africa) according to the manufacturer's protocol. Primer sequences are available on request. Glyceraldehyde-3-phosphate dehydrogenase was used as a normalization control.
For precise comparison of the expression levels between astrocyte-induction-related genes in meningeal cells (Table 1) , we amplified cDNA of a fragment of each gene by RT-PCR using RNAs extracted from meningeal cells and then cloned the cDNA into pGEM-T Easy Vector (Promega, Madison, WI, USA) according to the manufacturer's instructions. We measured the amount of gene expression using 1 ng of this cDNA by qPCR based on the value obtained with each cloned cDNA as a standard.
Luciferase assay
In advance, NS/PCs expanded for 4 days were replated on poly-L-ornithine/fibronectin-coated 12-well plates at a density of 5 9 10 5 cells per well (Fig. 5A ,B) or 24-well plates at a density of 2.5 9 10 5 per well (Fig. 5C ,D) and cultured. NS/PCs cultured overnight after this passage were then transfected with a plasmid containing the firefly luciferase gene under the regulation of a 2.5 kb Gfap promoter isolated from mouse strain 129 (GF1L) [26] or a modified construct as described below, using polyethylenimine (Polysciences). We introduced nucleotide substitutions into a STAT3-binding site (5 0 -TTCCGAGAA-
[21] in the Gfap promoter. Control transfection was performed with the sea pansy luciferase gene conjugated with the human elongation factor 1a promoter (EF1a). On the following day, each tested stimulant was added, and after 24 h, luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega) and a luminometer (ARVO Light; PerkinElmer, Waltham, MA, USA) according to the manufacturer's protocol. When we used fresh meninges as stimulants, NS/PCs and meninges were separated with a trans-well with a 3.0-lm pore insert (Corning, New York, NY, USA).
Inhibitor treatment
To inhibit JAK1 and 2, critical tyrosine kinases for the activation of STAT3 in the IL-6 family cytokine signaling pathway, 1 lM Rux (Selleck Chemicals, Houston, TX, USA) was used. As a BMP antagonist, 50 ngÁmL À1 recombinant human Noggin (R&D Systems, Minneapolis, MN, USA) was used. As RA receptor a antagonist, 1 lM Ro 415253 (Sigma-Aldrich) was used. Since Rux and Ro 415253 were dissolved in DMSO, 
Statistical analysis
The results presented are the average of at least three experiments, each performed in triplicate, with standard errors. Statistical analyses were performed by Fisher's exact test, Student's t-test, and the Kruskal-Wallis test using SPSS STATISTICS ver. 21 (IBM, New York, NY, USA). Differences were deemed significant if the probability value was < 0.05.
Results
Co-culturing with meningeal cells enhances astrocytic differentiation of NS/PCs
Since the niche for astrocytic differentiation of NS/ PCs should be composed of cells located in close proximity to NS/PCs themselves, NS/PCs, neurons, and meningeal cells were selected as candidate cells for the source of astrocyte-inducing factors in the developing brain. To analyze the contribution of these cells to NS/PCs fate specification, NS/PCs were isolated from mouse fetal telencephalon at embryonic day (E) 14 and cultured for 4 days to mimic the status of NS/PCs in the gliogenic phase. To observe the fate of NS/PCs, we also prepared NS/PCs infected with retroviruses engineered to express GFP (transduction efficiency: about 40-50%), and then co-cultured them with these three types of cells for 4 days (Fig. 1A) . GFP-labeled NS/PCs cultured with nonlabeled NS/PCs or with neurons hardly expressed astrocyte-specific markers, GFAP and aquaporin 4 (AQP4) (Fig. 1B,C,E,F) . In contrast, NS/PCs co-cultured with meningeal cells produced highly processed stellate cells expressing GFAP and AQP4 (Fig. 1D,G) . In this co-culture, about 30% and 50% of GFP-labeled NS/PCs became GFAP-and AQP4-positive, respectively (Fig. 1H ). Since our GFP transduction efficiency was~50%, there existed GFPnegative NS/PCs in the culture, which differentiated into GFAP-positive astrocytes. However, we cannot rule out a possibility that recently reported radial glialike cells in meninges [31] , which are GFP-negative, differentiated into GFAP-positive astrocytes in this culture condition. We also tested the effect of co-culturing with meningeal cells on neuronal differentiation and found no significant differences in the proportion of neuronal marker class III b tubulin (TUBB3)-positive cells (Fig. 1B,C,D,H) , suggesting that meningeal cells, but not NS/PCs or neurons, effectively induce differentiation of NS/PCs toward astrocytes.
Since co-culture experiments were not able to distinguish whether the effects of cell-cell physical contact or of soluble factors secreted from meninges were important to induce astrocytic differentiation of NS/ PCs, NS/PCs were cultured for 4 days in the presence of conditioned medium (CM) from isolated meningeal cells. As seen in Fig. 1I , meningeal CM strikingly induced GFAP-positive astrocytic differentiation of NS/PCs in a dose-dependent manner (Fig. 1J) , demonstrating that the meningeal cells secrete soluble factors which stimulate astrocytic differentiation of NS/PCs.
Meningeal cells express genes for astrocyteinduction-related factors
Having shown that meningeal cells secrete soluble factors that induce astrocytic differentiation of NS/PCs, we then attempted to identify the factors responsible for this meningeal activity. We extracted RNAs from NS/PCs, neurons, and meningeal cells at the time just before these cells had been used for co-culturing and analyzed the gene expression of candidates of astrocyte-induction-related factors by quantitative reverse transcription and polymerase chain reaction (RTqPCR). To ensure the characteristics of each type of cultured cell, we checked the expression of the respective cell-type-specific genes, hairy and enhancer of split 5 (Hes5, NS/PC marker), Tubb3 (neuronal marker), and Forkhead box C1 (FoxC1, meninges marker). As we expected, NS/PCs highly expressed Hes5 compared with the other two types of cells. In contrast, neurons and meningeal cells highly expressed Tubb3 and FoxC1, respectively (Fig. 2) . Since IL-6 family cytokines, BMPs, and RA have been shown to induce astrocytic differentiation [15, 16, 21, 32] , we examined the gene expression levels of Lif, Cntf, and Ct-1 as representatives of IL-6 family cytokines, Bmp2, 4, and 7, and RA synthesis-associated genes retinol dehydrogenase 10 (Rdh10) and retinaldehyde dehydrogenase 2 (Raldh2). The expression levels of Lif, Bmp4, and Raldh2 in meningeal cells were significantly higher than those in the other cell types (Fig. 2) . Among the meninges-expressed IL-6 family cytokines we quantified, the expression level of Lif was the highest ( Table 1) .
Although these experiments showed that dissociated and primary cultured meningeal cells induced astrocytic differentiation, the properties of these cells might have changed during culturing. Therefore, we collected freshly isolated meninges from E17 telencephalon (termed fresh meninges), and directly subjected them to analysis for the expression of genes of astrocyte-induction-related factors. Before comparing the expression in fresh meninges with that in cultured meningeal cells, we first compared the expression in fresh meninges with that in freshly isolated E17 cortex to confirm the higher expression of astrocyte-induction-related factors in meningeal cells in vivo. Almost all of the examined RT-qPCR analysis of representative genes of IL-6 family cytokines (Lif, Cntf, Ct-1), BMPs (Bmp2, Bmp4, Bmp7), and RA synthesis-related enzymes (Rdh10, Raldh2) in cells used in the co-culture assay. Y-axis shows the expression level relative to that in NS/PCs. The expression levels of Hes5, Tubb3, and Foxc1 were analyzed to ensure selective isolation of NS/PCs (blue bars) neurons (orange bars) and meninges (gray bars), respectively. Data in graphs are mean AE SE from six independent experiments (one-way ANOVA: Tukey's MC test, n = 6, ***P < 0.001, **P < 0.005, *P < 0.05).
genes for astrocyte-induction-related factors were expressed more highly in fresh meninges than in fetal cortex (Fig. 3) . We then compared the expression of these genes in fresh meninges with that in meningeal cells cultured for 3 days. We found that the expression of all of the genes for astrocyte-induction-related factors examined here was higher (or at least tended to be higher) in fresh meninges than in cultured meningeal cells (Fig. 4A) , suggesting that fresh meninges have even higher potential to induce astrocytic differentiation of NS/PCs compared with cultured meningeal cells. We also examined whether astrocyte-inductionrelated gene expression levels are altered as development progresses. Given that during the course of mouse development, astrocyte production starts at around E15 following the neurogenic phase and peaks around P3 [33] , the expression of astrocyte-inductionrelated genes is assumed to be increased from lategestation to postnatal stages. For the expression of Cntf and Bmp4, this was indeed the case, and the expression of BMP7 and Raldh2 also showed such a tendency, although it was not statistically significant (Fig. 4B) . On the other hand, Ct-1 showed decreased expression, while Lif and Rdh10 expression did not change much over time, and the expression of Lif was the highest among IL-6 family cytokines examined in fresh meninges (Table 1) . Taken together, these results suggest that astrocyte-induction-related genes are 
Raldh2
Gene expression/gene expression of E17 cortex Fig. 3 . Expression levels of genes for astrocyte-induction-related factors in fresh meninges and cortex at E17. The expression levels of genes for astrocyteinduction-associated factors in fresh meninges and the cortex from E17 mouse were examined by RT-qPCR. The graph represents relative expression levels of genes for astrocyte-induction-associated factors in E17 meninges (black bars), compared to E17 cortex from which meninges had been peeled (white bars). Data in graphs are mean AE SE. Statistical analyses were performed by Student's ttest (n = 4, ***P < 0.001, **P < 0.005, *P < 0.05). Tukey's MC test, n = 4, ***P < 0.001, **P < 0.005, *P < 0.05).
expressed in meninges in an appropriate developmental phase, reinforcing the importance of meninges for the astrocytic differentiation of NS/PCs in the developing brain.
Meninges-produced factors synergistically activate Gfap promoter
We next sought to examine how and to what extent the meninges-produced astrocyte-inducing factors affect the promoter activation of the best characterized astrocytic marker, Gfap. To this end, we performed reporter assays by using a luciferase construct fused with the mouse Gfap promoter (GF1L) [26] . When we cultured NS/PCs with fresh meninges separated from them by a membrane, the Gfap promoter was activated in a fresh meninges-dose-dependent manner (Fig. 5A) , confirming that meninges secrete soluble factors that induce astrocytic differentiation of NS/PCs. In this culture condition, we also observed that in addition to Gfap, expression of other astrocyte-specific marker genes (Aqp4, S100b and Aldehyde dehydrogenase1l1) was also upregulated by co-culturing with fresh meninges (not shown).
We then examined the effect of various individual astrocyte-inducing factors and their combinatorial treatment on Gfap promoter activation. Since we were not able to measure the concentration of the factors in vivo, we stimulated NS/PCs with generally used concentrations of the factors, i.e., BMP4 (50 ngÁmL À1 ) and RA (1 lM); however, we used LIF or CNTF at a concentration of 0.5 ngÁmL À1 to at least partly mimic the in vivo condition, because Lif and Cntf are expressed at much lower levels than Bmp4 in meningeal cells (Table 1) . Although treatment with each factor alone barely induced Gfap promoter activation, each of the combinatorial treatments stimulated the promoter synergistically, and the degree of activation was the highest when the cells were treated with LIF, BMP4, and RA simultaneously (Fig. 5B) . CNTF acted the same as LIF (data not shown), since they share the exactly the same downstream signaling molecules, including STAT3 [19, 34] .
To further confirm that IL-6 family cytokines, BMPs, and RA are critical factors secreted by meninges to induce astrocytic differentiation of NS/ PCs, we introduced mutations at their cognate transcription factor-binding sites in the Gfap promoter (for STAT binding [21] , Smad binding [35] , and RAR binding [21] ). To confirm the effect of each mutation in the promoter, we first stimulated the cells with the mixture of BMP, RA, and LIF (meninges mimicking 'cocktail'), and found that each single mutation or combination of these mutations suppressed the promoter activation (Fig. 5C) . Moreover, when we stimulated the cells with fresh meninges, similar effects of the mutations on the promoter activation were observed, and notably, the introduction of the triple mutation (STAT, Smad, and RAR target sites simultaneously) strongly reduced the promoter activation in response to the stimulation with meninges (Fig. 5D) . Finally, to confirm that the identified three factors secreted from meningeal cells, i.e., IL-6 family cytokines, BMPs, and RA, are indeed responsible for the induction of astrocytic differentiation of NS/PCs in our co-culture experiments, we attempted to inhibit each individual signaling pathway by using its specific inhibitor. Inhibition of each single signaling pathway (IL-6 family with ruxolitinib (RUX) [36] ; BMPs with Noggin [32, 37] ; RA with Ro415253 [38] ) alone could suppress GFAP-positive astrocytic differentiation of NS/PCs to some extent. However, combinatorial treatment with the three inhibitors completely suppressed the astrocytic differentiation of NS/PCs induced by meningeal cells (Fig. 5E,F) . These results indicate that IL-6 family cytokines, BMPs, and RA are the major players from the meninges that induce astrocytic differentiation of NS/PCs.
Discussion
In this study, we have shown that brain-covering meninges induce astrocytic differentiation of NS/PCs by secreting a number of soluble factors that have been reported to induce astrocytic differentiation. First, we revealed that NS/PCs co-cultured with meningeal cells dramatically expressed astrocyte-specific markers, GFAP or AQP4 (Fig. 1D,G) . Second, we showed that meninges-secreted soluble factors such as LIF, BMP4, and RA activated the Gfap promoter (Fig. 5B) and that introduction of mutations to the binding sequences of their downstream transcription factors, i.e., STAT, Smad, or RAR binding element, in the promoter suppressed this activation (Fig. 5C,D) . Third, we found that simultaneous inhibition of the LIF/BMPs/RA pathways totally canceled astrocyteinducing effect of co-cultured meningeal cells (Fig. 5E,  F) . Finally, we also demonstrated that the expression levels of these genes in meninges increased during brain development as the NS/PC differentiation propensity changed toward gliogenic.
Although many factors that show astrocyte-inducing activity in vitro have been identified [8, 15, 21, 26] , regions and/or cells in the fetal brain that secrete these factors have not been fully elucidated. We hypothesized that the 'niche' for astrocytic differentiation ), and Ro 415253 (1 lM) were used, respectively. Hoechst 33258 (1 : 500) was used for nuclear staining (inset E). (F) Quantification of GFAP-positive cells in (E). To assess differentiation of NS/PCs in vitro, at least 200 GFP-positive cells from each sample (n = 4) were counted. Each inhibitor significantly reduced the proportion of GFAP-positive cells among GFP-positive cells, and the combinatorial treatment with these three inhibitors completely inhibited astrogenesis (one-way ANOVA: Tukey's MC test, n = 4, ***P < 0.001, **P < 0.005, *P < 0.05).
should be in close contact with NS/PCs. NS/PCs in the VZ/SVZ extend radial processes whose end-feet directly contact the meninges [7, 25, 39] . Although a previous study reported that neuron-produced CT-1 induces astrocytic differentiation of NS/PCs in the developing brain [23] , NS/PCs co-cultured with neurons barely generated astrocytes in our experimental setting (Fig. 1F) . This discrepancy might be due to differences of the cellular density, neuronal subtypes, or the medium components used for neuronal culture. In addition, that report mainly focused on IL-6 family cytokines while the contribution of other astrocyteinducing factors was not investigated, and there was no extensive comparison of embryonic neurons with other tissue and/or cells. Considering these facts together with the finding that NS/PCs directly contact the meninges, we sought to examine in the present study the potential of meninges as a source of astrocyte-inducing factors. Both isolated meningeal cells and fresh meninges express Lif and Cntf (IL-6 family cytokines), and Bmps and RA synthesis-associated genes are known to participate in the induction of astrocytic differentiation [18, 40] .
The fact that meninges are present from the early stages of cortical development and appear to be necessary for normal corticogenesis and brain development [24, 37, 39] together with our findings here reveal that meninges are not merely simple sheets covering and protecting brain but have turned out to be a very important tissue which secretes numerous factors to regulate NS/PC behavior. Although meninges tend to be thought of as a simple tissue, they actually consist of three membranes: dura mater, arachnoid mater, and pia mater. The dura mater is the outer membrane attached to the skull, and it forms a sac that envelops the arachnoid and pia mater comprising the leptomeninges. In this study, we used the inner membranes, leptomeninges, consisting of meningeal cells that compose the subarachnoid space between the arachnoid mater and the pia mater, filled with cerebrospinal fluid. Since the large blood vessels of the brain lie in the subarachnoid space, leptomeninges consist of a heterogeneous cell population including fibroblasts, pericytes, endothelial cells, and smooth muscle cells [41] . In addition, it has been reported that meninges in the developing brain contain radial glialike cells resembling NS/PCs in the VZ/SVZ, which migrate to cortex and differentiate into neuronal lineage [31] . It was reported that LIF is secreted from endothelial cells and/or fibroblasts, and TGFb is secreted by smooth muscle cells, pericytes, and macrophages [41] . Although the mixture of these cells in meninges might be critical for the synergistic induction of astrocytic differentiation, we did not verify which cell type among the meningeal components secretes individual astrocyte-inducing factors; however, this will be an important issue to elucidate in future studies. Since NS/PC differentiation should be exquisitely managed for higher brain functions, fate determination regulated by the combination of multiple factors is considered to be highly likely. If only one particular factor were responsible by itself for governing NS/PC fate specification, pathological conditions that induced even a subtle inflammatory response in the embryo might drastically affect astrocytic differentiation in the developing brain and eventually result in neurological dysfunction.
As astrocytic differentiation starts at late-gestation and peaks at around birth, it would be reasonable to posit that sequential upregulation of astrocyte-inducing factors regulates developmental-stage-dependent fate decisions of NS/PCs. In fact, the expression levels of several genes for astrocyte-induction-associated factors in meninges were altered in patterns dependent on the developmental stage. While expression of Lif was stable throughout the examined developmental stages, expression of Cntf in addition to Bmp4, 7, and Raldh2 was upregulated (or at least tended to be) with developmental progression (Fig. 4B) . Since some astrocyteinduction-related factors are expressed more highly in meninges from P1 than E17, it would be also an intriguing question to examine whether meningeal cells isolated from P1 mice could further improve the NS/ PCs differentiation into astrocytes compared with those from E17 mice.
How do the IL-6 family cytokines, BMPs and RA synergistically induce astrocytic differentiation of NS/ PCs? We have previously shown that LIF-activated STAT3 and BMP-activated Smad1 form a complex bridged by p300/CBP to synergistically induce the Gfap promoter activation [15, 19] . We have also revealed that histone H3 acetylation around the STAT-binding site in the Gfap promoter is augmented in NS/PCs treated with RA, allowing STAT3 to gain access to the promoter more efficiently [21] and this probably holds true for the Smad-binding as well. These mechanistic scenarios could explain the synergistic action by these astrocyte-inducing factors. It seems likely that all three of these signaling factors are important for maximally efficient activation of the Gfap promoter, since the mutation of any one signal's downstream transcription factor-binding site dramatically suppressed the meninges-and LIF/BMP/RA cocktail-induced Gfap promoter activation (Fig. 5C,  D) . Moreover, combinatorial treatment with inhibitors for IL-6 family cytokines, BMPs, and RA completely abolished the meningeal cell-induced GFAP-positive cell production (Fig. 5E,F) , indicating that these three factors account for meninges-induced astrocytic differentiation of NS/PCs. Furthermore, it is worth noting that even a small amount of each factor (especially for LIF and CNTF), which barely activates the Gfap promoter by itself, can drastically activate the promoter when the factors are added together. Because the amounts of these factors may be very low under in vivo as compared with in vitro experimental conditions (in which large amounts of factors can be added), having such synergistic mechanisms may be critical for the efficient production of desired cell types with limited factors under physiological conditions.
Since dysfunction of astrocytes in the developing brain is involved in some neuronal disorders [3, 9, [11] [12] [13] [14] , elucidating the precise mechanisms underlying astrocytic differentiation in the developing brain and in pathological conditions may provide leads to the development of therapies for psychiatric or developmental disorders, although such possibilities must await further investigations.
